DNMR Danimer Scientific

Filed: 29 Dec 20, 4:12pm



Washington, D.C. 20549






Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934


Date of report (Date of earliest event reported): December 29, 2020


Danimer Scientific, Inc.
(Exact Name of Registrant as Specified in Charter)


Delaware 001-39280 82-1924518
(State or other jurisdiction
of incorporation)
 (Commission File Number) (I.R.S. Employer
Identification Number)


140 Industrial Boulevard
Bainbridge, Georgia
(Address of principal executive offices) (Zip code)


(229) 243-7075
(Registrant’s telephone number, including area code)


Live Oak Acquisition Corp.

774A Walker Rd.

Great Falls, Virginia 22066
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:


Title of each class Trading Symbol(s) Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per share DNMR The New York Stock Exchange
Warrants, each exercisable for one share of Class A Common Stock for $11.50 per share DNMR WS The New York Stock Exchange


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2).


Emerging growth company ☒


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐







Item 7.01Regulation FD Disclosure.


On December 29, 2020, Danimer Scientific, Inc., formerly known as Live Oak Acquisition Corp., issued a press release announcing the consummation of its previously announced business combination. A copy of such press release is furnished as Exhibit 99.1 hereto.


The information in Item 7.01 and Item 9.01 of this Current Report on Form 8-K shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.


Item 9.01Financial Statements and Exhibits.




99.1Press release dated December 29, 2020 announcing the closing of the business combination.







Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.


Dated: December 29, 2020


 By:/s/ John A. Dowdy, III
  Name: John A. Dowdy, III
  Title:Chief Financial Officer